Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T18:38:56.834Z.
Calculation as of: 2026-10-06T18:38:56.834Z.
Quote observation: 2026-10-06T18:35:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 85c5299a8cd03ba6ccd909ec362e0e14be7ffdf82dbb7ad991ebf1e2cdc97105
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Universe Pharmaceuticals Inc.
Market Cap
$2.82M
EV/FCF Ratio
N/A
| NAME | MARKET CAP | EV/FCF RATIO |
|---|---|---|
| Universe Pharmaceuticals Inc. (UPC) | $2.82M | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.75M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $2.97M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.03M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.61M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.57M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.56M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.16M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.16M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.20M | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
